Supplier
California Dermatology Institute PC
California Dermatology Institute PC was paid $15.39M by Medicaid between Jan 2018 and Dec 2024, across 73 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 21% of everything it billed.
33Billing provider infoCALIFORNIA DERMATOLOGY INSTITUTE PC
THOUSAND OAKS, CA 91320
THOUSAND OAKS, CA 91320
33aNPI1235671389assigned 11/07/2016
33bProvider typeNon-Pharmacy Dispensing Site
28Total paid$15.39M
24GClaims317,516
24DCodes billed73
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Non-Pharmacy Dispensing Site providers in California
Rank by total paid#2 of 22
Median peer was paid$112K
This provider vs. median138×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,565 | $89K | |
| 2019 | 18,184 | $2.70M | |
| 2020 | 14,323 | $697K | |
| 2021 | 38,352 | $1.49M | |
| 2022 | 66,613 | $3.25M | |
| 2023 | 92,704 | $4.23M | |
| 2024incomplete | 81,775 | $2.92M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 77,326 | 70,678 | $3.19M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 65,218 | 62,275 | $1.88M |
| 17110 | 11% | 24,498 | 22,541 | $1.62M | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 7.4% | 24,310 | 24,250 | $1.13M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.5% | 16,093 | 15,817 | $1.00M |
| 17004 | 6.2% | 9,234 | 8,436 | $949K | |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 5.9% | 318 | 219 | $909K |
| 11106 | 5.3% | 7,987 | 7,640 | $822K | |
| 11102 | 2.7% | 6,939 | 6,837 | $411K | |
| 15789 | 2.4% | 1,528 | 1,505 | $362K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.1% | 8,507 | 8,167 | $323K |
| 17311 | 1.9% | 689 | 665 | $290K |
61 more codes
| 96910 | 1.4% | 7,564 | $218K | |
| 11107 | 1.3% | 2,999 | $205K | |
| 17312 | 1.1% | 591 | $173K | |
| 11900 | 1.0% | 8,708 | $156K | |
| 11103 | <1% | 3,269 | $151K | |
| 17000 | <1% | 3,207 | $151K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 7,683 | $146K |
| A6010 | Collagen based wound filler, dry form, sterile, per gram of collagen | <1% | 237 | $110K |
| 17106 | <1% | 666 | $88K | |
| 96900 | <1% | 10,719 | $78K | |
| 10040 | <1% | 2,055 | $73K | |
| 17003 | <1% | 2,393 | $70K | |
| 11104 | <1% | 872 | $66K | |
| 11402 | <1% | 924 | $65K | |
| 13132 | <1% | 340 | $64K | |
| 13121 | <1% | 440 | $61K | |
| 15793 | <1% | 479 | $56K | |
| 96401 | <1% | 310 | $46K | |
| 99072 | <1% | 7,816 | $46K | |
| 17313 | <1% | 86 | $42K | |
| 13101 | <1% | 333 | $39K | |
| 99305 | <1% | 779 | $37K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,030 | $30K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 358 | $29K |
| 11403 | <1% | 426 | $28K | |
| A6219 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing | <1% | 270 | $25K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 301 | $23K |
| 54056 | <1% | 447 | $22K | |
| 99205 | Prolong outpt/office vis | <1% | 198 | $15K |
| 99307 | <1% | 913 | $14K | |
| 11300 | <1% | 555 | $14K | |
| 17314 | <1% | 44 | $14K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 972 | $13K |
| 11422 | <1% | 164 | $13K | |
| 11305 | <1% | 448 | $11K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 309 | $11K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,644 | $10K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 579 | $10K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 281 | $9K |
| 11200 | <1% | 308 | $8K | |
| 11055 | <1% | 476 | $7K | |
| 99304 | <1% | 218 | $7K | |
| 11442 | <1% | 129 | $6K | |
| 11056 | <1% | 242 | $5K | |
| 99000 | <1% | 341 | $4K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 33 | $4K |
| 69100 | <1% | 87 | $3K | |
| 0001A | <1% | 66 | $2K | |
| 0002A | <1% | 63 | $2K | |
| 12001 | <1% | 48 | $2K | |
| 11100 | <1% | 166 | $2K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 50 | $1K |
| 11310 | <1% | 49 | $1K | |
| 99336 | <1% | 46 | $931.20 | |
| 12031 | <1% | 12 | $831.64 | |
| 40490 | <1% | 16 | $803.57 | |
| 64650 | <1% | 13 | $693.44 | |
| 0003A | <1% | 18 | $640.00 | |
| 11105 | <1% | 13 | $615.71 | |
| 99347 | <1% | 26 | $478.55 | |
| 11101 | <1% | 40 | $186.66 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEZRA, NAVID (MD)